JRA1 meeting for fragment screening

The second JRA1 meeting to discuss progress in joint research activities leading to better provision of fragment and ligand screening facilities to the user community, has taken place in Amsterdam on 26/2/2017. All tasks are on track, and we expect to open the application process for such projects within February 2017, and the first provision of transnational user access within 2017.

A highlight of the meeting was the combined effort of NMR centres to validate the common iNEXT fragment library, which is well on track. Excellent progress in the Xray crystallography front,  has seen the first incarnations of pipelines  for fragment based drug discovery at Grenoble and at Diamond functional and validated and ready for iNEXT.